Catalent, Inc. to Present at the Morgan Stanley Global Health Care Conference

SOMERSET, N.J.–(BUSINESS WIRE)– Catalent, Inc. (NYSE:CTLT), the leading global provider of advanced
delivery technologies and development solutions for drugs, biologics and
consumer health products, today announced that John Chiminski, President
& Chief Executive Officer and Matthew Walsh, Executive Vice President &
Chief Financial Officer, will present at the Morgan Stanley Global
Health Care Conference at 10:35 a.m. ET on Tuesday, September 13, 2016
in New York City.

A live webcast of the presentation will be accessible through the
Company’s website at http://investor.catalent.com
and will be available for replay for 90 days following the event.

About Catalent, Inc.

Catalent, Inc. (NYSE:CTLT) is the leading global provider of advanced
delivery technologies and development solutions for drugs, biologics and
consumer health products. With over 80 years serving the industry,
Catalent has proven expertise in bringing more customer products to
market faster, enhancing product performance and ensuring reliable
clinical and commercial product supply. Catalent employs more than 8,700
people, including over 1,000 scientists, at 31 facilities across 5
continents and in fiscal 2015 generated more than $1.8 billion in annual
revenue. Catalent is headquartered in Somerset, N.J. For more
information, please visit www.catalent.com.

More products. Better treatments. Reliably supplied.™

View source version on businesswire.com: http://www.businesswire.com/news/home/20160823005987/en/